PharmaEngine (4162)

Currency in TWD
73.60
+0.50(+0.68%)
Closed·
High dividend Yield
4162 is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
72.5073.80
52 wk Range
63.90123.00
Key Statistics
Bid/Ask
66.50 / 66.60
Prev. Close
96.2
Open
73
Day's Range
72.5-73.8
52 wk Range
63.9-123
Volume
425.3K
Average Volume (3m)
541.99K
1-Year Change
-24.12%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
4162 Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
0.00
Downside
-100.00%
Members' Sentiments
Bearish
Bullish
ProTips
High shareholder yield

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Strong Buy

PharmaEngine Company Profile

PharmaEngine, Inc., a biopharmaceutical company, engages in the development of drugs and therapeutic drugs for treating cancer in Taiwan. It offers ONIVYDE, a cancer medicine that blocks an enzyme called topoisomerase I, which is involved in copying cell DNA needed to make new cells. The company is developing PEP07, a CHK1 inhibitor, which is in Phase 1 clinical trial for the treatment of hematological tumors and solid tumors. PharmaEngine, Inc. was incorporated in 2002 and is headquartered in Taipei, Taiwan.

Compare 4162 to Peers and Sector

Metrics to compare
4162
Peers
Sector
Relationship
P/E Ratio
6.3x2.4x−0.6x
PEG Ratio
0.02−0.550.00
Price/Book
2.2x5.6x2.6x
Price / LTM Sales
4.2x25.1x3.3x
Upside (Analyst Target)
-0.0%39.9%
Fair Value Upside
Unlock12.8%4.4%Unlock

Analyst Ratings

0 Buy
1 Hold
0 Sell
Ratings:
1 analysts
Overall Consensus
Neutral

Analysts 12-Month Price Target:

Average 0.00
Firm
ArticlePositionPrice TargetUpside / DownsideFrom Price TargetActionDate

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 11.63%
Dividend Yield
8.15%
Industry Median 0.93%
Annualised payout
6.00
Paid annually
5-Years Growth
+64.38%
Growth Streak

Earnings

Latest Release
Nov 05, 2025
EPS / Forecast
0.94 / 0.68
Revenue / Forecast
219.50M / 220.00M
EPS Revisions
Last 90 days

FAQ

What Is the PharmaEngine (4162) Share Price Today?

The live PharmaEngine share price today is 73.60

What Stock Exchange Does PharmaEngine (4162) Trade On?

PharmaEngine is listed and trades on the Taipei Exchange.

What Is the Ticker (Stock Symbol) for PharmaEngine?

The stock symbol (also called a 'ticker') for PharmaEngine is "4162."

Does PharmaEngine Pay Dividends? What’s The Current 4162 Dividend Yield?

Yes, 4162 Pays Dividends to its Shareholders. The current PharmaEngine dividend yield is 8.15%.

What Is the Current PharmaEngine Market Cap?

As of today, PharmaEngine market capitalisation is 10.57B.

What Is PharmaEngine's (4162) Earnings Per Share (TTM)?

The PharmaEngine EPS is currently 11.63 (Trailing Twelve Months).

When Is the Next PharmaEngine Earnings Date?

PharmaEngine's next earnings report will be released on 18 Mar 2026.

Is 4162 a Buy or Sell From a Technical Analyst Perspective?

Based on today's PharmaEngine moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.

How Many Times Has PharmaEngine Stock Split?

PharmaEngine has split 3 times. (See the 4162 stock split history page for full effective split date and price information.)

How Many Employees Does PharmaEngine Have?

PharmaEngine has 44 employees.

What is the current trading status of PharmaEngine (4162)?

As of 11 Jan 2026, PharmaEngine (4162) is trading at a price of 73.60, with a previous close of 96.20. The stock has fluctuated within a day range of 72.50 to 73.80, while its 52-week range spans from 63.90 to 123.00.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.